Invesco Ltd.
NYSE:IVZAsset Management
-$0.41 today
- Market cap
- $12.59B
- Beta
- 1.59
- P/E (TTM)
- -53.4
- EPS (TTM)
- -$0.54
- Dividend yield
- 2.94%
Volume 5.54M
Average 5.41M
IVZ Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Invesco Ltd.NYSE: IVZ
Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026
Cost of revenue declines year over year
Q2 FY2026 cost of revenue of $8.1M fell 99.2% year over year, behind the -45.2% change in trailing-twelve-month cost of revenue. Sequentially, it fell 98.7% from the prior quarter. Over 3 fiscal years it compounded at +0.1% a year.
Context
- Cost of revenue amounted to 56.8% of revenue in FY2025, down 9.8 pp from a year earlier.
- Cost of revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -99.2% toward the trailing-twelve-month pace of -45.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 3.62B USD
- Year-over-year change
- -10.3%
- 4-year CAGR
- -2.8%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.62B | -10.3% |
| FY2024 | 2024-12-31 | 4.04B | +8.9% |
| FY2023 | 2023-12-31 | 3.71B | +2.8% |
| FY2022 | 2022-12-31 | 3.61B | -11.1% |
| FY2021 | 2021-12-31 | 4.06B | — |
Cost of Revenue vs competitors
How IVZ compares with its peers on the latest reported figures
- IVZ's LTM Jun 2026 cost of revenue of $2.25B is the 4th highest of the 11 companies compared; the peer median is $564.56M.
- Its year-over-year change of -45.2% is the 7th highest of 10, against a peer median of -32.9%.
- Cost of revenue amounts to 32.6% of revenue for IVZ, versus a peer median of 26.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $9.86B | +14.6% | +12.2% | 49.8% | |
| LTM Jun 2026 | $8.08B | -2.8% | +9.7% | 51.5% | |
| LTM Jun 2026 | $3.02B | +74.0% | +43.6% | 32.4% | |
| LTM Jun 2026 | $2.25B | -45.2% | +0.1% | 32.6% | |
| LTM Jun 2026 | $2.22B | -35.8% | -2.2% | 29.3% | |
| LTM Sep 2026 | $605.32M | -32.9% | -0.3% | 23.9% | |
| LTM Sep 2026 | $523.8M | -17.2% | +8.4% | 41.6% | |
| LTM Sep 2026 | $255.6M | -74.1% | -31.7% | 9.8% | |
| LTM Mar 2026 | $21.47M | -61.5% | -31.1% | 21.6% | |
| LTM Mar 2026 | $7.67M | -47.0% | +8.5% | 23.2% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding IVZ) | $564.56M | -32.9% | +8.4% | 26.6% | |
Competitors are the stored peer set for IVZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 6.89B | 6.05B | 5.72B | 6.07B | 6.38B |
| Cost of Revenue | 4.06B | 3.61B | 3.71B | 4.04B | 3.62B |
| Gross Profit | 2.83B | 2.44B | 2.01B | 2.03B | 2.75B |
| Gross Margin | 41.1% | 40.3% | 35.1% | 33.4% | 43.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 522.7M | 588.2M | 649.7M | 676M | 660.5M |
| Operating Expenses | 1.05B | 1.12B | 2.44B | 1.2B | 3.45B |
| Depreciation & Amortization | 205.3M | 195.3M | 182.8M | 179.6M | 155.9M |
| EBITDA | 2.8B | 1.53B | 15.4M | 1.24B | (390.8M) |
| EBITDA Margin | 40.6% | 25.3% | 0.3% | 20.5% | -6.1% |
| Operating Income | 1.79B | 1.32B | (434.8M) | 832.1M | (695.7M) |
| Operating Margin | 25.9% | 21.8% | -7.6% | 13.7% | -10.9% |
| Interest Income | 25.2M | 24.4M | 47.8M | 58.9M | 53.9M |
| Interest Expense | 94.7M | 85.2M | 70.5M | 58M | 82.5M |
| Other Income / Expenses | 712.3M | (70M) | 196.9M | 173.2M | 316.3M |
| Income Before Tax | 2.5B | 1.25B | (237.9M) | 1.01B | (379.4M) |
| Pre-Tax Margin | 36.3% | 20.6% | -4.2% | 16.6% | -5.9% |
| Income Tax Expense | 531.1M | 322.2M | (69.7M) | 252.9M | (204.6M) |
| Net Income | 1.63B | 920.7M | (96.9M) | 774.8M | (281.7M) |
| Net Margin | 23.6% | 15.2% | -1.7% | 12.8% | -4.4% |
| EPS (Basic) | 3.01 | 1.50 | (0.73) | 1.18 | (1.61) |
| EPS (Diluted) | 2.99 | 1.49 | (0.73) | 1.18 | (1.60) |
| Weighted Avg Shares | 462.8M | 457.5M | 454.8M | 457M | 451.2M |
| Weighted Avg Shares (Diluted) | 465.4M | 459.5M | 456.2M | 457.7M | 453.8M |
Invesco Ltd.
NYSE:IVZ
Intrinsic Alpha fair value
Locked
Current Price
$28.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.